4.6 Article

Phenothiazine Inhibits Neuroinflammation and Inflammasome Activation Independent of Hypothermia After Ischemic Stroke

Journal

MOLECULAR NEUROBIOLOGY
Volume 58, Issue 12, Pages 6136-6152

Publisher

SPRINGER
DOI: 10.1007/s12035-021-02542-3

Keywords

Ischemic stroke; Chlorpromazine and promethazine (C plus P); JAK2/STAT3; p38; HIF-1 alpha; FoxO1

Categories

Funding

  1. National Natural Science Foundation of China [81871838, 82001277, 82101436]
  2. Beijing Tongzhou District Financial Fund
  3. Laboratory Development Funds of Luhe Hospital

Ask authors/readers for more resources

Chlorpromazine and promethazine exhibit neuroprotective effects by inhibiting neuroinflammation and NLRP3 inflammasome activation, as well as suppressing the activation of key pathways such as JAK2/STAT3, p38, and HIF-1 alpha/FoxO1.
A depressive or hibernation-like effect of chlorpromazine and promethazine (C + P) on brain activity was reported to induce neuroprotection, with or without induced-hypothermia. However, the underlying mechanisms remain unclear. The current study evaluated the pharmacological function of C + P on the inhibition of neuroinflammatory response and inflammasome activation after ischemia/reperfusion. A total of 72 adult male Sprague-Dawley rats were subjected to 2 h middle cerebral artery occlusion (MCAO) followed by 6 or 24 h reperfusion. At the onset of reperfusion, rats received C + P (8 mg/kg) with temperature control. Brain cell death was detected by measuring CD68 and myeloperoxidase (MPO) levels. Inflammasome activation was measured by mRNA levels of NLRP3, IL-1 beta, and TXNIP, and protein quantities of NLRP3, IL-1 beta, TXNIP, cleaved-Caspase-1, and IL-18. Activation of JAK2/STAT3 pathway was detected by the phosphorylation of STAT3 (p-STAT3) and JAK2 (p-JAK2), and the co-localization of p-STAT3 and NLRP3. Activation of the p38 pathway was assessed with the protein levels of p-p38/p38. The mRNA and protein levels of HIF-1 alpha, FoxO1, and p-FoxO1, and the co-localization of p-STAT3 with HIF-1 alpha or FoxO1 were quantitated. As expected, C + P significantly reduced cell death and attenuated the neuroinflammatory response as determined by reduced CD68 and MPO. C + P decreased ischemia-induced inflammasome activation, shown by reduced mRNA and protein expressions of NLRP3, IL-1 beta, TXNIP, cleaved-Caspase-1, and IL-18. Phosphorylation of JAK2/STAT3 and p38 pathways and the co-localization of p-STAT3 with NLRP3 were also inhibited by C + P. Furthermore, mRNA levels of HIF-1 alpha and FoxO1 were decreased in the C + P group. While C + P inhibited HIF-1 alpha protein expression, it increased FoxO1 phosphorylation, which promoted the exclusion of FoxO1 from the nucleus and inhibited FoxO1 activity. At the same time, C + P reduced the co-localization of p-STAT3 with HIF-1 alpha or FoxO1. In conclusion, C + P treatment conferred neuroprotection in stroke by suppressing neuroinflammation and NLRP3 inflammasome activation. The present study suggests that JAK2/STAT3/p38/HIF-1 alpha/FoxO1 are vital regulators and potential targets for efficacious therapy following ischemic stroke.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available